Leslie J. Browne
Président chez Phrixus Pharmaceuticals, Inc.
Profil
Leslie J.
Browne is currently the Chairman at Phrixus Pharmaceuticals, Inc. Prior to this, Browne held the position of President, Chief Executive Officer & Director at Pharmacopeia LLC from 2004 to 2008.
Browne also served as the Chairman at New Jersey Technology Council from 2007 to 2011.
Additionally, Browne was an Independent Director at Genelabs Technologies, Inc. from 2007 to 2009.
Browne previously worked as the Vice President at Berlex, Inc. from 1990 to 2000.
Browne was also the President at Sevion Therapeutics, Inc. in 2014.
Furthermore, Browne served as the Chief Operating Officer at Iconix Biosciences, Inc. from 2001 to 2004 and as the President at.
Schering Berlin Venture Corp.
Browne's earlier experience includes being the Chief Operating Officer at GeneTrace Systems, Inc. from 2000 to 2001.
Browne holds a doctorate degree from the University of Michigan, which was conferred in 1978, and an undergraduate degree from the University of Strathclyde, which was conferred in 1972.
Postes actifs de Leslie J. Browne
| Sociétés | Poste | Début |
|---|---|---|
Phrixus Pharmaceuticals, Inc.
 Phrixus Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Phrixus Pharmaceuticals, Inc. develops Carmeseal for DMD and for acute decompensated heart failure. It is repurposing Poloxamer for heart failure for which the only cure is heart transplantation. The company was founded by Thomas A. Collet and Bruce Markham in 2006 and is headquartered in Ann Arbor, MI. | Président | 18/02/2011 |
Anciens postes connus de Leslie J. Browne
| Sociétés | Poste | Fin |
|---|---|---|
Sevion Therapeutics, Inc.
 Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | Directeur Général | 16/05/2014 |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Directeur/Membre du Conseil | 08/01/2009 |
Pharmacopeia LLC
 Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | President | 09/04/2008 |
Iconix Biosciences, Inc.
 Iconix Biosciences, Inc. BiotechnologyHealth Technology Iconix Biosciences is a multi-disciplinary company that integrates the skills and knowledge necessary for the creation of the world's largest toxicogenomics database of microarray and pharmacology data (DrugMatrix) with the informatics expertise and computer skills required to mine and interpret this vast body of information. Based on the data in DrugMatrix, Iconix has developed a library of Drug Signatures, genomic biomarkers that are predictive of specific toxicological endpoints and mechanisms of action. DrugMatrix and Drug Signatures provide a uniform source of molecular toxicology information, analytical tools, data mining algorithms and biomarkers to optimize drug candidates and predict their potential efficacy and toxicity before they advance to expensive preclinical and clinical development studies. Iconix's platform includes an integrated database architecture (IXIS) to bridge genomics and drug design, novel bio and chemoinformatics software, and advanced expression array and cellular expression assay development capabilities. This technology platform is coupled with an unparalled group of molecular toxicologists and bioinformaticians with years of experience in applying the tools and contextual data to provide clients with answers to critical scientific questions. Iconix has focused these capabilities on a line of products, licenses, services, and long-term collaborations. Iconix provides reports on customer compounds to classify them and help prioritize and select the best leads for advancement at all stages of discovery. Iconix has also entered exclusive alliances with collaborators to apply toxicogenomics data and know-how to customized drug discovery and development projects. Founded in 1998 by distinguished scientists and pharmaceutical industry professionals, Iconix has won the backing of some of the highest profile venture capitalists in the biotechnology and information technology industries. Iconix has also established alliances with leading global technology companies for the development and commercialization of its products, including MDS Pharma Services, Spotfire, Amersham Biosciences, MDL Information Systems, and Affymetrix. | Directeur des opérations | 01/07/2004 |
GeneTrace Systems, Inc.
 GeneTrace Systems, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTrace Systems, Inc. provides drug discovery and development services. The company is based in Alameda, CA. The company was founded by Joseph Monforte. | Directeur des opérations | 01/01/2001 |
Formation de Leslie J. Browne
| University of Michigan | Doctorate Degree |
| University of Strathclyde | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Health Technology |
Berlex, Inc.
 Berlex, Inc. Pharmaceuticals: MajorHealth Technology Berlex, Inc. manufactured pharmaceutical company. It developed novel diagnostics and therapeutics, which address unmet medical needs. It used to researches, develops, manufactures and markets ethical pharmaceuticals in five strategic areas such as female healthcare, diagnostic imaging, dermatology, oncology and therapeutics. The company was headquartered in Wayne, NJ | Health Technology |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | Commercial Services |
Pharmacopeia LLC
Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Health Technology |
Iconix Biosciences, Inc.
Iconix Biosciences, Inc. BiotechnologyHealth Technology Iconix Biosciences is a multi-disciplinary company that integrates the skills and knowledge necessary for the creation of the world's largest toxicogenomics database of microarray and pharmacology data (DrugMatrix) with the informatics expertise and computer skills required to mine and interpret this vast body of information. Based on the data in DrugMatrix, Iconix has developed a library of Drug Signatures, genomic biomarkers that are predictive of specific toxicological endpoints and mechanisms of action. DrugMatrix and Drug Signatures provide a uniform source of molecular toxicology information, analytical tools, data mining algorithms and biomarkers to optimize drug candidates and predict their potential efficacy and toxicity before they advance to expensive preclinical and clinical development studies. Iconix's platform includes an integrated database architecture (IXIS) to bridge genomics and drug design, novel bio and chemoinformatics software, and advanced expression array and cellular expression assay development capabilities. This technology platform is coupled with an unparalled group of molecular toxicologists and bioinformaticians with years of experience in applying the tools and contextual data to provide clients with answers to critical scientific questions. Iconix has focused these capabilities on a line of products, licenses, services, and long-term collaborations. Iconix provides reports on customer compounds to classify them and help prioritize and select the best leads for advancement at all stages of discovery. Iconix has also entered exclusive alliances with collaborators to apply toxicogenomics data and know-how to customized drug discovery and development projects. Founded in 1998 by distinguished scientists and pharmaceutical industry professionals, Iconix has won the backing of some of the highest profile venture capitalists in the biotechnology and information technology industries. Iconix has also established alliances with leading global technology companies for the development and commercialization of its products, including MDS Pharma Services, Spotfire, Amersham Biosciences, MDL Information Systems, and Affymetrix. | Health Technology |
Phrixus Pharmaceuticals, Inc.
Phrixus Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Phrixus Pharmaceuticals, Inc. develops Carmeseal for DMD and for acute decompensated heart failure. It is repurposing Poloxamer for heart failure for which the only cure is heart transplantation. The company was founded by Thomas A. Collet and Bruce Markham in 2006 and is headquartered in Ann Arbor, MI. | Health Technology |
| Schering Berlin Venture Corp. | |
GeneTrace Systems, Inc.
GeneTrace Systems, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTrace Systems, Inc. provides drug discovery and development services. The company is based in Alameda, CA. The company was founded by Joseph Monforte. | Commercial Services |
New Jersey Technology Council
 New Jersey Technology Council Miscellaneous Commercial ServicesCommercial Services New Jersey Technology Council provides business development, education and advocacy services. It serves communications, e-business, multimedia, consumer technologies, manufacturing, engineering and energy sectors. The company was founded in 1996 and is headquartered in New Brunswick, NJ. | Commercial Services |
